- Report
- March 2024
- 182 Pages
Global
From €3262EUR$3,374USD£2,804GBP
€3624EUR$3,749USD£3,115GBP
- Report
- November 2023
- 119 Pages
Global
From €5752EUR$5,950USD£4,944GBP
- Report
- October 2023
- 178 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- December 2023
- 326 Pages
Global
From €4057EUR$4,197USD£3,487GBP
- Report
- January 2024
- 121 Pages
Global
From €5317EUR$5,500USD£4,570GBP
- Report
- January 2024
- 110 Pages
Global
From €5752EUR$5,950USD£4,944GBP
- Report
- April 2024
- 349 Pages
Global
From €4785EUR$4,950USD£4,113GBP
- Report
- October 2023
- 182 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 145 Pages
Global
From €3045EUR$3,150USD£2,617GBP
- Newsletter
- April 2024
Global
€2895EUR$2,995USD£2,489GBP
- Report
- March 2020
- 293 Pages
Global
From €4736EUR$4,899USD£4,071GBP
- Report
- July 2019
- 189 Pages
Global
From €1329EUR$1,375USD£1,142GBP
€2658EUR$2,750USD£2,285GBP
- Report
- June 2021
- 142 Pages
Global
From €2658EUR$2,750USD£2,285GBP
€5317EUR$5,500USD£4,570GBP
- Report
- August 2022
- 67 Pages
Global
- Report
- April 2019
- 15 Pages
Global
- Report
- April 2019
- 75 Pages
Global
From €4785EUR$4,950USD£4,113GBP
- Report
- January 2022
- 122 Pages
Global
From €4592EUR$4,750USD£3,947GBP
- Report
- March 2021
- 106 Pages
Middle East, Africa
From €1450EUR$1,500USD£1,246GBP
- Report
- November 2021
- 1184 Pages
Global
From €5800EUR$6,000USD£4,985GBP
Cell reprogramming is a biotechnology process that involves the conversion of a cell from one type to another. It is used to create induced pluripotent stem cells (iPSCs) from adult cells, which can then be used to study diseases, develop new treatments, and create personalized medicine. Cell reprogramming is also used to create cell models of diseases, which can be used to study the underlying mechanisms of the disease and develop new therapies. Additionally, cell reprogramming can be used to create cell-based therapies, such as gene therapy, which can be used to treat genetic diseases.
Cell reprogramming is a rapidly growing field, with many companies investing in the technology. Some of the companies in the market include Ginkgo Bioworks, Cellular Dynamics International, Fate Therapeutics, and Pluristem Therapeutics. Show Less Read more